Why ED Treatment Pricing Varies So Much Between Providers
Not a quality shortcut. Here's what's actually driving the spread between providers.
Two providers, same underlying condition, meaningfully different prices — and it's not because one is cutting corners. Here's what actually drives the spread.
Format is the biggest driver
Compounded medication generally costs less than brand-name product, reflecting a genuinely different manufacturing and regulatory pathway, not a quality shortcut. Peptide-based options like PT-141 sit in their own cost category entirely, reflecting a different production process than either pill format.
MadeMed
Compounded tadalafil through a licensed pharmacy network, positioned as a lower-cost alternative to brand-name treatment for people who qualify after evaluation.
Compounded medication notice: compounded formulations are not FDA-approved. Compounding pharmacies prepare medications under a licensed clinician’s prescription; effectiveness and safety have not been independently evaluated by the FDA.
View Offer Paid LinkBusiness model is the second driver
A subscription-based provider prices differently than a pay-per-fill one, reflecting different assumptions about your long-term relationship with them. Neither model is inherently cheaper across every scenario — it depends on how consistently you'd actually use the treatment.
What this means for comparing prices fairly
A price difference between two providers isn't meaningful on its own — it only tells you something once you know whether you're comparing the same format, the same commitment structure, and the same included services. Confirm current specifics directly with each provider rather than assuming a lower number automatically means a better deal.